Clinical efficacy study of Guizhi Fuling capsule combined with metformin in patients with polycystic ovary syndrome and insulin resistance

LAI Yu-feng, PAN Jian-feng, DENG Xiao-mei, SHEN Lan

Chinese Journal of Practical Gynecology and Obstetrics ›› 2025, Vol. 41 ›› Issue (8) : 852-854.

PDF(859 KB)
PDF(859 KB)
Chinese Journal of Practical Gynecology and Obstetrics ›› 2025, Vol. 41 ›› Issue (8) : 852-854. DOI: 10.19538/j.fk2025080117

Clinical efficacy study of Guizhi Fuling capsule combined with metformin in patients with polycystic ovary syndrome and insulin resistance

Author information +
History +

Abstract

Objective To study the clinical efficacy of Guizhi Fuling capsules combined with metformin in patients with polycystic ovary syndrome (PCOS) and insulin resistance. Methods A total of 108 patients with PCOS and insulin resistance admitted to Jiangnan Hospital Affiliated to Zhejiang University of Traditional Chinese Medicine from July 2021 to May 2024 were selected and divided into study group and control group according to the random number table method,with 54 cases in each group. The control group was treated with metformin,and the study group was combined with Guizhi Poria capsule on this basis. The clinical efficacy, estrogen and sex hormone levels and pregnancy-related indicators before and after treatment were compared between the two groups. Results (1) The improvement rate of menstrual disorders,clinical symptoms,and return to normal sex hormone levels in the study group were significantly higher than those in the control group [97.67% (42/43) vs. 80.95% (34/42),92.59% (50/54) vs. 77.78% (42/54),94.44% (51/54) vs. 79.63% (43/54),all P<0.05]. (2) After treatment,the normal range rate of progesterone,testosterone and estradiol in the study group was significantly higher than that in the control group [83.33% (45/54) vs. 55.56% (30/54),88.89% (48/54) vs. 53.70% (29/54),85.19% (46/54) vs. 59.26% (32/54),P<0.05]. (3) The menstrual recovery rate,ovulation rate and pregnancy rate of the study group were significantly higher than those of the control group [98.15% (53/54) vs. 62.96% (34/54),81.48% (44/54) vs. 51.85% (28/54),48.15% (26/54) vs. 14.81% (8/54) (P<0.05). Conclusion Guizhi Fuling capsule combined with metformin in the treatment of PCOS and insulin resistance can further improve the efficacy, regulate estrogen secretion and increase pregnancy rate.

Key words

Guizhi Fuling capsule / metformin / polycystic ovary syndrome / insulin resistance / sex hormone

Cite this article

Download Citations
LAI Yu-feng , PAN Jian-feng , DENG Xiao-mei , et al. Clinical efficacy study of Guizhi Fuling capsule combined with metformin in patients with polycystic ovary syndrome and insulin resistance[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2025, 41(8): 852-854 https://doi.org/10.19538/j.fk2025080117

References

[1]
王阳, 邢雅雯, 邢玉, 等. 补肾化痰方联合针刺治疗肥胖型多囊卵巢综合征的临床疗效观察[J]. 中国计划生育和妇产科, 2022, 14(4):75-80. DOI:10.3969/j.issn.1674-4020.2022.04.20.
[2]
高玲, 龙宇航, 黄荷凤. 多囊卵巢综合征加重心血管损伤新机制研究[J]. 中华内分泌代谢杂志, 2024, 40(4):275-282. DOI:10.3760/cma.j.cn311282-20240205-00060.
[3]
黄永群, 沈方方, 黄润强, 等. 生酮饮食联合炔雌醇环丙孕酮片治疗超重或肥胖多囊卵巢综合征患者的疗效及对性激素水平的影响[J]. 中国性科学, 2022, 31(5):64-68. DOI:10.3969/j.issn.1672-1993.2022.05.017.
[4]
沈歆媛, 郭盛. Alström综合征代谢紊乱及分子机制研究进展[J]. 中国实用儿科杂志, 2025, 40(3):256-260.DOI:10.19538/j.ek2025030612.
[5]
Genazzani AD, Battipaglia C, Petrillo T, et al. Familial diabetes predisposes PCOS patients to insulin resistance (IR),reproductive impairment and hepatic dysfunction:effects of d-chiro inositol (DCI) and alpha lipoic acid (ALA) administration on hepatic insulin extraction (HIE) index[J]. Gynecol Endocrinol, 2022, 38(8):681-688. DOI:10.1080/09513590.2022.2089107.
[6]
中华医学会妇产科学分会内分泌学组及指南专家组. 多囊卵巢综合征中国诊疗指南[J]. 中华妇产科杂志, 2018, 53(1):2-6. DOI:10.3760/cma.j.issn.0529-567x.2018.01.002.
[7]
魏智慧, 曹亚芳, 繆醇. 清解阳明汤联合二甲双胍治疗多囊卵巢综合征患者痤疮及高胰岛素血症临床观察[J]. 中华中医药学刊, 2023, 41(11):66-69. DOI:10.13193/j.issn.1673-7717.2023.11.015.
[8]
庞颖, 刘雁峰, 吴豆豆, 等. 补肾调肝降浊法治疗肥胖型多囊卵巢综合征的思路探析[J]. 中华中医药杂志, 2023, 38(6):2668-2671.
[9]
孙琴, 范旭虹. 肥胖型多囊卵巢综合征患者血清miR-124、IGFBP-3与糖脂代谢[J]. 中国计划生育学杂志, 2021, 29(6):1258-1262. DOI:10.3969/j.issn.1004-8189.2021.06.044.
PDF(859 KB)

Accesses

Citation

Detail

Sections
Recommended

/